dovitinib
Showing 1 - 24 of 24
Solid Tumors Trial in Hospitalet de Llobregat, Fuenlabrada, Madrid (Dovitinib, Dovitinib + Paclitaxel)
Terminated
- Solid Tumors
- Dovitinib
- Dovitinib + Paclitaxel
-
Hospitalet de Llobregat, Barcelona, Spain
- +2 more
Apr 15, 2020
Gastric Cancer Trial in Seoul (Dovitinib)
Completed
- Gastric Cancer
- Dovitinib
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 6, 2020
Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)
Completed
- Gastrointestinal Stromal Tumors
- dovitinib
-
Seoul,, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Solid Tumors, Hepatic Impairment Trial in Worldwide (Dovitinib)
Completed
- Solid Tumors
- Hepatic Impairment
- Dovitinib
-
Los Angeles, California
- +11 more
Dec 17, 2020
Breast Cancer Trial in Houston (Dovitinib)
Completed
- Breast Cancer
- Dovitinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 22, 2019
Prostate Cancer Trial in Houston (Dovitinib, Abiraterone Acetate, Prednisone)
Terminated
- Prostate Cancer
- Dovitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 26, 2019
Breast Cancer Trial in Washington (Dovitinib, Aromatase Inhibitors)
Terminated
- Breast Cancer
- Dovitinib
- Aromatase Inhibitors
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jan 15, 2018
NSCLC, Colorectal Cancer Trial in Sacramento (Dovitinib)
Completed
- Non-Small Cell Lung Cancer
- Colorectal Cancer
- Dovitinib
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
Jan 5, 2018
Adrenocortical Carcinoma Trial in Spain (Dovitinib)
Completed
- Adrenocortical Carcinoma
- Dovitinib
-
Santiago de Compostela, A Coruña, Spain
- +6 more
Apr 24, 2017
Von Hippel-Lindau Syndrome Trial in Houston (Dovitinib)
Terminated
- Von Hippel-Lindau Syndrome
- Dovitinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 21, 2016
Colorectal Cancer, Pancreas Cancer Trial in Washington (Dovitinib)
Terminated
- Colorectal Cancer
- Pancreas Cancer
- Dovitinib
-
Washington, District of ColumbiaGeorgetown University- Lombardi Cancer Center
Jun 7, 2016
First or Second Recurrence of Glioblastoma Trial in Bonn (Dovitinib)
Unknown status
- First or Second Recurrence of Glioblastoma
- Dovitinib
-
Bonn, GermanyDepartment of Neurology and Center of Integrated Oncology, Unive
Apr 18, 2016
Metastatic Breast Cancer Trial in Worldwide (Dovitinib, Fulvestrant, Dovitinib Placebo)
Terminated
- Metastatic Breast Cancer
- Dovitinib
- +2 more
-
Chandler, Arizona
- +66 more
May 26, 2016
Advanced Malignant Pleural Mesothelioma, MPM Trial in Canada (Dovitinib)
Terminated
- Advanced Malignant Pleural Mesothelioma
- MPM
- Dovitinib
-
Calgary, Alberta, Canada
- +4 more
Sep 16, 2015
Hepatocellular Carcinoma Trial in Worldwide (dovitinib, sorafenib)
Metastatic Renal Cell Carcinoma Trial in Worldwide (Dovitinib, Sorafenib)
Completed
- Metastatic Renal Cell Carcinoma
- Dovitinib
- Sorafenib
-
Fayetteville, Arkansas
- +198 more
Nov 5, 2015
Clear Cell Renal Cell Carcinoma Trial in Auckland (Dovitinib)
Unknown status
- Clear Cell Renal Cell Carcinoma
- Dovitinib
-
Auckland, New ZealandAuckland Hospital
Feb 1, 2015
Prostate Cancer Trial in Las Vegas (Standard ADT, Dovitinib)
Withdrawn
- Prostate Cancer
- Standard ADT
- Dovitinib
-
Las Vegas, NevadaComprehensive Cancer Centers of Nevada
Jan 15, 2015
Thyroid Cancer Trial in Seoul (Dovitinib)
Completed
- Thyroid Cancer
- Dovitinib
-
Seoul, Korea, Republic ofDivision of Medical Oncology, Yonsei Cancer Center, Yonsei Unive
Nov 26, 2014
Metastatic Clear Cell Renal Cancer Trial in London (Dovitinib, Everolimus)
Completed
- Metastatic Clear Cell Renal Cancer
- Dovitinib
- Everolimus
-
London, United KingdomBarts Health NHS Trust
Nov 11, 2013
Squamous NSCLC Trial in Seoul (Dovitinib)
Unknown status
- Squamous NSCLC
- Dovitinib
-
Seoul, Korea, Republic ofSamsung Medical Center
May 22, 2013
Multiple Myeloma Trial (Dovitinib, Bortezomib, Dexamethasone)
Withdrawn
- Multiple Myeloma
- Dovitinib
- +2 more
- (no location specified)
Feb 18, 2013